| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | tyrosine-protein phosphatase non-receptor type 12 | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | tyrosine-protein phosphatase non-receptor type 6 | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | receptor-type tyrosine-protein phosphatase epsilon | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | v-atpase subunits | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| tiludronic acid | hydroxylapatite | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | antagonist,binder |
| tiludronic acid | adenosine triphosphate (atp) | small molecule | NA | drugbank | Serum[MeSHID:D044967] Osteitis Deformans[MeSHID:D010001] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,vet_approved | inhibitor |
| click here to return to the previous page | ||||||||